BBPvsOZEMETF Comparison
Virtus LifeSci Biotech Products ETF (BBP) and Roundhill GLP-1 & Weight Loss ETF (OZEM) belong to the same industry segment: Tomorrow's Treatments. Both ETFs have the same top 3 sector exposures: and Health Care. BBP is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.59% for OZEM. BBP is up 9.25% year-to-date (YTD) with +$30M in YTD flows. OZEM performs worse with -10.57% YTD performance, and +$12M in YTD flows. Run a side-by-side ETF comparison of BBP and OZEM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
BBP vs OZEM performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP OZEM | -1.38%-3.86% | +7.00%-3.67% | +9.25%-10.57% | +43.65%+11.27% | +60.05%n/a | +58.90%n/a |
| Flows | BBP OZEM | +$4M+$2M | +$26M-$4M | +$30M+$12M | +$42M+$9M | +$45M- | +$38M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP OZEM | +28.75%+20.46% | +24.06%+22.78% | +24.00%n/a | +26.36%n/a |
| Max drawdown | BBP OZEM | -7.49%-8.22% | -9.59%-19.51% | -25.54%n/a | -37.87%n/a |
| Max drawdown duration | BBP OZEM | 37d54d | 48d137d | 292dn/a | 760dn/a |
BBP | OZEM | |
Last sale 6/12/2026 at 1:30 PM | $87.17 | $30.56 |
| Previous close 06/11/2026 | $86.80 | $30.85 |
| Consolidated volume 06/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BBP | OZEM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BBP | OZEM | |
|---|---|---|
| Last price | $87.17 | $30.56 |
| 1D performance | +0.42% | -0.95% |
| AuM | $78.43 M | $49.70 M |
| E/R | 0.79% | 0.59% |
BBP | OZEM | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | VIRTUS Investment Partners | Roundhill Investments |
| Benchmark | LifeSci Biotechnology Products Index | - |
| N° of holdings | 55 | 19 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | May 21, 2024 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
